Democratic Republic of Congo announced the end of an almost six-month Ebola outbreak in the west of the country on Wednesday as health authorities looked to apply lessons from the successful response ...
Once an antibody latches on to a pathogen, broadly neutralizing antibodies inactivate it (as their name implies). This is ...
Despite the mechanisms that made it a “biologically plausible” candidate, the study found that participants who took the drug ...
During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...
The Trump administration is scrambling to rehire Centers for Disease Control and Prevention staffers that were let go as part ...
In a sobering interview, the respected infectious disease expert expresses concern over our willful deconstruction of parts ...
1don MSN
‘We are more than blood diamonds and Ebola’: Sierra Leone seeks investment in a post-aid world
INTERVIEW: The chief minister of Sierra Leone tells Nick Ferris why he believes the country is ripe for investment and how ...
A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19 ...
Stockpiling vaccines that protect against multiple different coronaviruses could reduce deaths and the need for lockdowns during future global pandemics, according to a new study.
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback